PNA-based multivalent scaffolds activate the dopamine D2 receptor

ACS Medicinal Chemistry Letters

Volumn 6, Issue 4, 2015, Pages 425-429

  Dix, Andrew V ^a   Conroy, Jennie L ^b   George Rosenker, Kara M ^a   Sibley, David R ^b   Appella, Daniel H ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

dopamine D2 receptor; multivalent display; Peptide nucleic acid; self assembly

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; MOLECULAR SCAFFOLD; PEPTIDE NUCLEIC ACID;

ARTICLE; EC50; LIGAND BINDING; PHARMACOPHORE; PRIORITY JOURNAL; SYNTHESIS;

EID: 84927648209     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml500478m     Document Type: Article

References (51)

1. Hisahara, S.; Shimohama, S. Dopamine Receptors and Parkinsons Disease Int. J. Med. Chem. 2011, 2011, 1-16
2. 2 Receptors Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 7673-7675
3. 2 Receptor Dimeration Mol. Brain 2010, 25, 1-9
4. 2 Receptor Heteromer Regulates Signaling Cascades Involved in Addiction: Potential Relevance to Adolescent Drug Susceptibility Dev. Neurosci. 2014, 36, 287-296
5. Wang, G.-J.; Volkow, N. D.; Logan, J.; Pappas, N. R.; Wong, C. T.; Zhu, W.; Netusll, N.; Fowler, J. S. Brain Dopamine and Obesity Lancet 2001, 357, 354-357
6. 2 Receptors in Addiction-Like Reward Dysfunction and Compulsive Eating in Obese Rats Nat. Neurosci. 2010, 13, 635-641
7. Beaulieu, J. M.; Gainetdinov, R. R. The Physiology, Signaling, and Pharmacology of Dopamine Receptors Pharmacol. Rev. 2011, 63, 182-217
8. 2 Receptor Dimers in Human and Rat Brain FEBS Lett. 1998, 441, 383-86
9. 2 Dopamine Receptors Exist as Oligomers in the Cell Mol. Pharmacol. 2000, 58, 120-128
10. 2 Receptors Form Higher Order Oligomers at Physiological Expression Levels EMBO J. 2008, 27, 2293-2304
11. Perreault, M. L.; Hasbi, A.; ODowd, B. F.; George, S. R. Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance Neuropsychopharmacology 2014, 39, 156-168
12. Franco, R. Neurotransmitter Receptor Heteromers in Neurodegenerative Diseases and Neural Plasticity J. Neural. Transm. 2009, 116, 983-987
13. Fuxe, K.; Marcellino, D.; Rivera, A.; Diaz-Cabiale, Z.; Filip, M.; Gago, B.; Roberts, D. C.; Langel, U.; Genedani, S.; Ferraro, L.; de la Calle, A.; Narvaez, J.; Tanganelli, S.; Woods, A.; Agnati, L. F. Receptor-Receptor Interactions Within Receptor Mosaics. Impact on Neuropsychopharmacology Brain Res. Rev. 2008, 58, 415-452
14. 2 Receptors Enhances Heterodimer Formation: A Mechanism for Receptor Cross-Talk? Mol. Pharmacol. 2005, 67, 1697-1704
15. George, S. R.; ODowd, B. F.; Lee, S. P. G-Protein-Coupled Receptor Oligomerization and Its Potential for Drug Discovery Nat. Rev. Drug Discovery 2002, 1, 808-820
16. Ferré, S.; Navarro, G.; Casadó, V.; Cortés, A.; Mallol, J.; Canela, E. I.; Lluís, C.; Franco, R. G Protein-Coupled Receptor Heteromers as New Targets for Drug Development Prog. Mol. Biol. Transl. Sci. 2010, 41-52
17. Messer, W. S. J. Bivalent Ligands for G Protein-Coupled Receptors Curr. Pharm. Des. 2004, 10, 2015-2020
18. Berque-Bestel, I.; Lezoualch, F.; Jockers, R.; Gainetdinov, R. R. Bivalent Ligands as Specific Pharmacological Tools for G Protein-Coupled Receptors Curr. Drug Discovery Technol. 2008, 5, 312-318
19. Hiller, C.; Kuhhorn, J.; Gmeiner, P.; Class, A. G-Protein-Coupled Receptor (GPCR) Dimers and Bivalent Ligands J. Med. Chem. 2013, 56, 6542-6559
20. Portoghese, P. S.; Ronsisvalle, G.; Larson, D. L.; Yim, C. B.; Sayre, L. M.; Takemori, A. E. Opiod Agonist and Antagonist Bivalent Ligands as Receptor Probes Life Sci. 1982, 31, 1283-1286
21. Erez, M.; Takemori, A. E.; Portoghese, P. S. Narcotic Antagonistic Potency of Bivalent Ligands Which Contain B-Naltrexamine. Evidence for Bridging Between Proximal Recognition Sites J. Med. Chem. 1982, 25, 847-849
22. 2 Receptor Heteromers J. Med. Chem. 2009, 52, 5590-5602
23. Kuhhorn, J.; Hubner, H.; Gmeiner, P. Bivalent Dopamine D2 Receptor Ligands: Synthesis and Binding Properties J. Med. Chem. 2011, 54, 4896-4903
24. 2 Affinity and Potency ACS Med. Chem. Lett. 2012, 3, 991-996
25. McRobb, F. M.; Crosby, I. T.; Yuriev, E.; Lane, J. R.; Capuano, B. Homobivalent Ligands of the Atypical Antipsychotic Clozapine: Design, Synthesis, and Pharmacological Evaluation J. Med. Chem. 2012, 55, 1622-1634
26. 2 Receptor Med.Chem.Comm 2013, 4, 1290-1296
27. Fasting, C.; Schalley, C. A.; Weber, M.; Seitz, O.; Hecht, S.; Koksch, B.; Dernedde, J.; Graf, C.; Knapp, E. W.; Haag, R. Multivalency as a Chemical Organization and Action Principle Angew. Chem., Int. Ed.. 2012, 51, 10472-10498
28. Mammen, M.; Choi, S.-K.; Whitesides, G. M. Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors Angew. Chem., Int. Ed. 1998, 37, 22754-22794
29. Barnard, A.; Smith, D. K. Self-Assembled Multivalency: Dynamic Ligand Arrays for High-Affinity Binding Angew. Chem., Int. Ed. 2012, 51, 6572-6581
30. Martos, V.; Castreño, P.; Valero, J.; de Mendoza, J. Binding to Protein Surfaces by Supramolecular Multivalent Scaffolds Curr. Opin. Chem. Biol. 2008, 12, 698-706
31. Dix, A. V.; Moss, S. M.; Phan, K.; Hoppe, T.; Paoletta, S.; Kozma, E.; Gao, Z.-G.; Durell, S. R.; Jacobson, K. A.; Appella, D. H. Programmable Nanoscaffolds That Control Ligand Display to a G-Protein-Coupled Receptor in Membranes To Allow Dissection of Multivalent Effects J. Am. Chem. Soc. 2014, 12296-12303
32. Englund, E. A.; Appella, D. H. γ-Substituted Peptide Nucleic Acids Constructed From l -Lysine are a Versatile Scaffold for Multifunctional Display Angew. Chem., Int. Ed. 2007, 46, 1414-1418
33. Englund, E. A.; Wang, D.; Fujigaki, H.; Sakai, H.; Micklitsch, C. M.; Ghirlando, R.; Martin-Manso, G.; Pendrak, M. L.; Roberts, D. D.; Durell, S. R.; Appella, D. H. Programmable Multivalent Display of Receptor Ligands Using Peptide Nucleic Acid Nanoscaffolds Nat. Commun. 2012, 3, 614
34. Diezmann, F.; Seitz, O. DNA-Guided Display of Proteins and Protein Ligands for the Interrogation of Biology Chem. Soc. Rev. 2011, 40, 5789-5801
35. Abendroth, F.; Bujotzek, A.; Shan, M.; Haag, R.; Weber, M.; Seitz, O. DNA-Controlled Bivalent Presentation of Ligands for the Estrogen Receptor Angew. Chem., Int. Ed. 2011, 50, 8592-8596
36. Abendroth, F.; Seitz, O. Double-Clicking Peptides onto Phosphorothioate Oligonucleotides: Combining Two Proapoptotic Agents in One Molecule Angew. Chem., Int. Ed. 2014, 53, 10504-10509
37. Scheibe, C.; Bujotzek, A.; Dernedde, J.; Weber, M.; Seitz, O. DNA-Programmed Spatial Screening of Carbohydrate-Lectin Interactions Chem. Sci. 2011, 2, 770-775
38. Eberhard, H.; Diezmann, F.; Seitz, O. DNA as a Molecular Ruler: Interrogation of a Tandem SH2 Domain with Self-Assembled, Bivalent DNA-Peptide Complexes Angew. Chem., Int. Ed. 2011, 50, 4146-4150
39. Winssinger, N. Nucleic Acid-Programmed Assemblies: Translating Instruction into Function in Chemical Biology Chimia 2013, 67, 340-348
40. Englund, E. A.; Appella, D. H. Synthesis of γ-Substituted Peptide Nucleic Acids: A New Place to Attach Fluorophores without Affecting DNA Binding Org. Lett. 2005, 7, 3465-3467
41. Egholm, M.; Buchardt, O.; Christensen, L.; Behrens, C.; Freier, S. M.; Driver, D. A.; Berg, R. H.; Kim, S. K.; Norden, B.; Nielsen, P. E. PNA Hybridizes to Complementary Oligonucleotides Obeying the Watson-Crick Hydrogen-Bonding Rules Nature 1993, 365, 566-568
42. Wittung, P.; Nielsen, P. E.; Buchardt, O.; Egholm, M.; Norden, B. DNA-Like Double Helix Formed By Peptide Nucleic Acid Nature 1994, 368, 561-563
43. Hacksell, U.; Svensson, U.; Nilsson, J. L. G. N-Alkylated 2-Aminotetralins: Central Dopamine-Receptor Stimulating Activity J. Med. Chem. 1979, 22, 1469-1475
44. 2 Receptor Agonsits and Antagonists on Bombesin-Induced Behaviors Eur. J. Pharmacol. 1990, 191, 281-293
45. Bakthavachalam, V.; Baindur, N.; Madras, B. K.; Neumeyer, J. L. Fluorescent Probes for Dopamine Receptors: Synthesis and Characterization of Fluorescein and 7-Nitrobenz-2-oxa-1,3-diazol-4-yl Conjugates of D-1 and D-2 Receptor Ligands J. Med. Chem. 1991, 34, 3235-3241
46. Nielsen, P. E.; Egholm, M.; Berg, R. H.; Buchardt, O. Sequence-Selective Recognition of DNA by Strand Displacement with a Thymine-Substituted Polyamide Science 1991, 254, 1497-1500
47. Porcheddu, A.; Giacomelli, G. Peptide Nucleic Acids (PNAs), A Chemical Overview Curr. Med. Chem. 2005, 12, 2561-2599
48. van Der Lee, M. M.; Bras, M.; van Koppen, C. J.; Zaman, G. J. β-Arrestin Recruitment Assay for the Identification of Agonists of the Sphingosine 1-Phosphate Receptor EDG1 J. Biomol. Screening 2008, 13, 986-998
49. Free, R. B.; Chun, L. S.; Moritz, A. E.; Miller, B. N.; Doyle, T. B.; Conroy, J. L.; Padron, A.; Meade, J. A.; Xiao, J.; Hu, X.; Dulcey, A. E.; Han, Y.; Duan, L.; Titus, S.; Bryant-Genevier, M.; Barnaeva, E.; Ferrer, M.; Javitch, J. A.; Beuming, T.; Shi, L.; Southall, N. T.; Marugan, J. J.; Sibley, D. R. Discovery and Characterization of a G protein-Biased Agonist That Inhibits β-Arrestin Recruitment to the D2 Dopamine Receptor Mol. Pharmacol. 2014, 86, 96-105
50. 4 Dopamine Receptors Int. J. Neuropsychopharmacol. 2013, 16, 445-458
51. Weber, M.; Bujotzek, A.; Haag, R. Quantifying the Rebinding Effect in Multivalent Chemical Ligand-Receptor Systems J. Chem. Phys. 2012, 137, 054111